UBS raised the firm’s price target on Intuitive Surgical (ISRG) to $600 from $585 and keeps a Neutral rating on the shares. Strong procedure volume growth and system placements are likely to help sustain the stock’s momentum, the analyst tells investors in a post-earnings note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG: